Observational studyCardiovascular diabetology2021

Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study.

Enrico Longato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.